Philips
FDA grants Philips clearance for 3D TAVI software | Regulatory news for the week of August 25, 2014
Philips wins FDA nod for 3D TAVI planning software
Dentsply, Philips Healthcare land $39M in Pentagon deals
Zoll Medical, Philips withdraw appeal in defibrillator patent spat
Smith & Nephew plans to reveal new strategy for mature markets | Medtech Wall Street news for the week of July 28, 2014
Philips’ healthcare business suffers in Q2
Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.
Haemonetics taps outgoing Covidien CFO Dockendorff for board | Personnel Moves
Ex-Neuronetics, Abiomed exec is Intact Vascular’s new CEO | Personnel Moves
Intact Vascular said yesterday that it named medical device veteran Bruce Shook as its new president & CEO.
FDA chides Philips Respironics over infant sleep monitor manufacturing
Philips Healthcare’s (NYSE:PHG) Respironics unit is in the FDA’s cross-hairs after regulators inspected a manufacturing facility responsible for infant sleep apnea monitors that were the subject of a recall.